Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01337245 · ClinicalTrials.gov registry record · Phase 3
Emergency Treatment of Coral Snake Envenomation With Antivenom
A Phase 3 study of Coral Snake Bite and Toxic Effect of Coral Snake Venom, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 3
- Development phase
- 26
- Enrollment target
- 5
- Study locations
NCT01337245 is a Phase 3 study of Coral Snake Bite and Toxic Effect of Coral Snake Venom that has completed, run by University of Arizona. The registered enrollment target is 26 participants. The trial reports 5 study locations across 2 states.
The verdict
NCT01337245, a Phase 3 study of Coral Snake Bite and Toxic Effect of Coral Snake Venom, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 26 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to see whether a new F(ab')2 antivenom will prevent injury and death from the bite of a coral snake. Funding Source - FDA OOPD.
Conditions Studied
Interventions
- DRUG Snake (Micrurus) North American immune F(ab')2 Equine
Study Locations (5)
Florida
- Florida Hospital Deland - DeLand
- Lee Memorial Hospital - Fort Myers
- St. Lucie Medical Center - Port Saint Lucie
- Tampa General Hospital - Tampa
Arizona
- Banner University Medical Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-11-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01337245
The ClinicalTrials.gov registry entry for NCT01337245 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coral Snake Bite appearing as the primary indexed condition, and to 1 intervention - of which Snake (Micrurus) North American immune F(ab')2 Equine is the first listed.
NCT01337245 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT01337245 about?
NCT01337245 is a clinical study titled "Emergency Treatment of Coral Snake Envenomation With Antivenom". The purpose of this study is to see whether a new F(ab')2 antivenom will prevent injury and death from the bite of a coral snake. Funding Source - FDA OOPD.
What is the current status of trial NCT01337245?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 26 participants. The study started on 2012-05. Estimated completion is 2016-11-11.
What conditions does trial NCT01337245 study?
This clinical trial studies the following conditions: Coral Snake Bite, Toxic Effect of Coral Snake Venom.
What interventions are being tested in trial NCT01337245?
The interventions under investigation include: Snake (Micrurus) North American immune F(ab')2 Equine (DRUG).
Who is sponsoring clinical trial NCT01337245?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01337245 being conducted?
This trial has 5 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.